Health Dictionary Find a Doctor

Follicular lymphoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Overview

Follicular lymphoma presents in the age group of 60-65 with systemic symptoms of fever, weight loss, anorexia, night sweats and other organ dependent symptoms based on the metastatic spread of the lymphoma. Complications arise from the systemic effects of the lymphoma and metastasis. The prognosis is evaluated from follicular lymphoma international prognostic index which divides patients into 3 groups.

Natural history

Natural history

Complications

Complications

  • Skin reactions
  • Bone marrow suppression
  • Secondary cancers
  • Gastric obstruction
  • Urethral obstruction
  • Renal failure
  • Infertility
  • Heart disease (Heart failure, valvular defects, pericarditis)
  • Lung disease (Pleural effusion, lung mass)
  • Mediastinal mass
  • Immune system deficiency
Prognosis

Prognosis

  • Follicular Lymphoma International Prognostic Index (FLIPI) is used for the evaluation of prognosis.[5][6]
  • It includes the following:
    • Age >60 years
    • Bone marrow involvement
    • Hemoglobin level <12.0 g/dl
    • Greatest diameter of the largest involved node >6 cm
    • Elevated serum β-2 microglobulin level
  • The FLIPI divides patients into 3 groups:
    • Low (0-1 risk factor)
    • Intermediate (2 risk factors)
    • High (≥ 3 risk factors)
  • The 10-year mortality of low group is 96%.
  • The 10-year mortality of intermediate group is 71%.
  • The 10-year mortality of high group is 37%.
References

References

  1. Kridel R, Sehn LH, Gascoyne RD (2012). “Pathogenesis of follicular lymphoma”. J Clin Invest. 122 (10): 3424–31. doi:10.1172/JCI63186. PMC 3461914. PMID 23023713.
  2. “A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project”. Blood. 89 (11): 3909–18. 1997. PMID 9166827.
  3. Winberg CD, Nathwani BN, Bearman RM, Rappaport H (1981). “Follicular (nodular) lymphoma during the first two decades of life: a clinicopathologic study of 12 patients”. Cancer. 48 (10): 2223–35. PMID 7028244.
  4. Fernández de Larrea C, Martínez-Pozo A, Mercadal S, García A, Gutierrez-García G, Valera A; et al. (2011). “Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma”. Br J Haematol. 153 (3): 334–40. doi:10.1111/j.1365-2141.2011.08596.x. PMID 21375524.
  5. Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R; et al. (2004). “Follicular lymphoma international prognostic index”. Blood. 104 (5): 1258–65. doi:10.1182/blood-2003-12-4434. PMID 15126323.
  6. Martin AR, Weisenburger DD, Chan WC, Ruby EI, Anderson JR, Vose JM; et al. (1995). “Prognostic value of cellular proliferation and histologic grade in follicular lymphoma”. Blood. 85 (12): 3671–8. PMID 7780151.

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH